DXB 2.60% 37.5¢ dimerix limited

DXB Media thread., page-2

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274
    Hi Wasabi,

    Thanks for starting a media thread, I think we are going to need this in the near future.

    I watched this interview this morning, a recap for most of us, but good information for new investors especially around the unmet clinical need in FSGS.

    Just as an aside here, can’t remember if we already discussed this, but Pfizer canned a Ph2 trial in FSGS fairly recently. If we are successful in ACTION 3 I think we will see a lot of interest from BP.

    https://www.clinicaltrialsarena.com/features/pipeline-moves-pfizer-focal-segmental-glomerulosclerosis/

    As per discussion around the remaining 80% of the globe for licencing deals on the table, I think someone else mentioned previously…but I picked up on that big smile on Nina’s face when she said they have been very busy lately & looking forward to updating the market in due course. So it’s body language, it could mean nothing but it was noticeable - Nina looked excited. I have watched a lot of her interviews. See what others think.

    Have a great day All.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
-0.010(2.60%)
Mkt cap ! $208.9M
Open High Low Value Volume
39.0¢ 39.0¢ 37.3¢ $538.4K 1.421M

Buyers (Bids)

No. Vol. Price($)
23 536997 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 90112 6
View Market Depth
Last trade - 14.31pm 07/11/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.